Prognostic and Clinical Value of Interleukin 6 and CD45+CD14+ Inflammatory Cells with PD-L1+/PD-L2+ Expression in Patients with Different Manifestation of Ovarian Cancer.

J Immunol Res · 2020 · PMC7545411 · PMID 33062717

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The percentage of CD45 + CD14 + PD-L1 + cells was higher among the OC-infiltrating cells than in PF and in PF in comparison to PB; however, these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Prognostic and Clinical Value of Interleukin 6 and CD45<sup>+</sup>CD14<sup>+</sup> Inflammatory Cells with PD-L1<sup>+</sup>/PD-L2<sup>+</sup> Expression in Patients with Different Manifestation of Ovarian Cancer.

The sentences